Prognosis
India to Boost Drug Ingredient Output to Pare China Reliance
- Pandemic impacted supply of essential medicines across nations
- India wants to cut reliance on inputs from China for exports
Photographer: Dhiraj Singh/Bloomberg
This article is for subscribers only.
India plans to ramp up production of pharmaceutical ingredients and become an alternative supplier for global drugmakers hit by factory shutdowns in China due to the coronavirus outbreak.
The Indian government has aggressively begun implementing a policy to ramp up local output and emerge as an alternate to China, according to people familiar with the plan who asked not to be identified as discussions are not public yet. The so-called “China-plus one” strategy involves identifying essential drug ingredients, providing incentives to domestic manufacturers and reviving ailing state-run drugmakers, they said.